Search
Apellis Pharmaceuticals Inc
APLSAdd to Watchlist
41.030USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
5.25BMarket Cap
38.75P/E TTM
Apellis Pharmaceuticals Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
1.00B
28.46%
EPS(YoY)
0.18
111.11%
Analyst Rating
2026-07-04
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Apellis Pharmaceuticals Inc?
According to Apellis Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 1.00B, with a year-on-year change of 28.46.
What are the current assets of Apellis Pharmaceuticals Inc?
According to Apellis Pharmaceuticals Inc's FY2025 earnings report, its current assets were 1.01B, with a year-on-year change of 28.63.
What are the total assets of Apellis Pharmaceuticals Inc?
According to Apellis Pharmaceuticals Inc's FY2025 earnings report, its total assets of Apellis Pharmaceuticals Inc were 1.08B, with a year-on-year change of 21.49.
What are the total liabilities of Apellis Pharmaceuticals Inc?
According to Apellis Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Apellis Pharmaceuticals Inc were 705.11M, with a year-on-year change of 7.40.
What is the total equity of Apellis Pharmaceuticals Inc?
According to Apellis Pharmaceuticals Inc's FY2025 earnings report, its total equity of Apellis Pharmaceuticals Inc was 370.15M, with a year-on-year change of 61.96.
What is the net investment of Apellis Pharmaceuticals Inc?
According to Apellis Pharmaceuticals Inc's FY2025 earnings report, its net investment of Apellis Pharmaceuticals Inc was -313.00K, with a year-on-year change of 22.33.
What is the net financing of Apellis Pharmaceuticals Inc?
According to Apellis Pharmaceuticals Inc's FY2025 earnings report, its net financing of Apellis Pharmaceuticals Inc was 8.88M, with a year-on-year change of -94.05.
What is the Earnings Per Share (EPS) of Apellis Pharmaceuticals Inc?
According to Apellis Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 0.18, with a year-on-year change of 111.11.
What is the net margin of Apellis Pharmaceuticals Inc?
According to Apellis Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was 2.23, with a year-on-year change of 108.81.
What is the gross margin of Apellis Pharmaceuticals Inc?
According to Apellis Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 89.81, with a year-on-year change of 5.75.
What is the debt-to-asset ratio of Apellis Pharmaceuticals Inc?
According to Apellis Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 42.35, with a year-on-year change of -17.24.
What is the Return on Equity (ROE) of Apellis Pharmaceuticals Inc?
According to Apellis Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was 7.48, with a year-on-year change of 108.00.
What is the Return on Assets (ROA) of Apellis Pharmaceuticals Inc?
According to Apellis Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was 2.28, with a year-on-year change of 109.66.
What is the operating profit of Apellis Pharmaceuticals Inc?
According to Apellis Pharmaceuticals Inc's FY2025 earnings report, its operating profit was 55.43M, with a year-on-year change of 133.60.